Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Congenica announces a new contract with the Institute of Immunology and Genetics, a leading molecular genetic laboratory in Kaiserslautern, Germany
Why my five-year-old daughter is my inspiration as we fight to understand her sister’s epilepsy
March 26 is #Purpleday, an international awareness day that aims to get people talking about epilepsy and raise awareness of the condition. Congenica welcomes guest blogger Adam Clatworthy to tell ...
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health selects Congenica clinical decision support platform and NGS data analysis software to provide answers for undiagnosed rare disease patients
Congenica signs distribution agreement with AmpliTech in France
Congenica, the digital health company enabling rapid and accurate analysis of genomic data, announces a distribution agreement with AmpliTech.
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Congenica, the company enabling rapid and accurate NGS data analysis to transform lives, today announces the appointment of Kamraan Shariff.
Rare Disease Day 2021 - Live Blog
The main objective of Rare Disease Day is to raise awareness amongst the public & decision-makers about rare diseases and their impact on patients' lives.
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Genomic sequencing has the potential to rapidly analyze critically ill babies and children and also to predict a response to infectious diseases and potential therapeutic compounds.
Why a diagnosis is so important for rare disease patients
Maybe you are an aunt or uncle of a child or may have friends who have children. Whatever the relationship you have, children are life-changing.
David Atkins joins the National Genomics Board as BIA SME representative
David Atkins, CEO of NGS data analysis software company Congenica, has joined the National Genomics Board to advise on the UK national genomics strategy.
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Congenica and Gabriel will develop a highly automated somatic cancer clinical interpretation software platform.
Webinar on Demand: Enabling Genomic Medicine
Genomic medicine has opened the possibility to transform the health and wellness of individuals around the world with life-changing diagnoses and treatments that would never have been previously ...
Congenica Contributes to Key Priority within UK Rare Disease Framework
The UK’s Department of Health has published its UK Rare Disease Framework, setting out the key priorities for the rare disease community.